ČCHING-TAO, Čína, 9. března 2024 /PRNewswire/ — Firma Hisense, globální společnost působící v oblasti výroby a prodeje spotřební elektroniky a spotřebičů, oznámila nové partnerství se značkou Xbox, jehož cílem je povýšit zážitky z domácího hraní a zábavy na novou úroveň prostřednictvím špičkové technologie laserových displejů. Continue Reading Hisense and Microsoft joint together for Designed for… Continue reading Společnost Hisense navázala spolupráci se značkou Xbox a své špičkové laserové displeje tím uvádí také do světa herního průmyslu
Category: Newswire
Statement: Assistance on the Way for Low-Income Older Americans
ARLINGTON, Va., March 9, 2024 /PRNewswire/ — The following is a statement from Ramsey Alwin, President and CEO of the National Council on Aging (NCOA), on yesterday’s passage of the federal appropriations package in the Senate: “We applaud Congress for funding critical assistance for low-income older Americans in today’s federal appropriations package. The $62.5 million… Continue reading Statement: Assistance on the Way for Low-Income Older Americans
AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) AT AAD 2024
SPROUT 52-Week Data Demonstrate Durable Response and Consistent Safety Profile of Oral Otezla in Children with Moderate to Severe Plaque Psoriasis Late-Breaking Phase 3 Study of Otezla in Palmoplantar Pustulosis Achieves Primary and Secondary Endpoints at 16 Weeks THOUSAND OAKS, Calif., March 9, 2024 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced new, 52-week results from the Phase… Continue reading AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) AT AAD 2024
Henning’s Wisconsin Cheese Ranks in Top 20 at World Championship Cheese Contest
KIEL, Wis., March 9, 2024 /PRNewswire/ — Henning’s Wisconsin Cheese took home three awards at the 2024 World Championship Cheese Contest, including two Best of Class honors for their Aged Cheddar Midget (cured 9 to 18 months) and Dragon’s Breath Cheddar Cheese. Their Aged Cheddar Midget (cured 9 to 18 months) placed Top 20 in… Continue reading Henning’s Wisconsin Cheese Ranks in Top 20 at World Championship Cheese Contest
Pelage Presents Late-Breaking Data at AAD 2024 Meeting Demonstrating PP405 Activates Human Hair Follicle Stem Cells Ex Vivo and in Phase 1 Clinical Study
– Potent topical MPC inhibitor, based on discovery of a metabolic switch, reawakens dormant hair follicle stem cells to stimulate hair growth – PP405 demonstrates statistically significant activation of Ki67 in the hair follicle, a well-established marker of stem cell proliferation LOS ANGELES, March 9, 2024 /PRNewswire/ — Pelage Pharmaceuticals, a clinical-stage regenerative medicine company pioneering a… Continue reading Pelage Presents Late-Breaking Data at AAD 2024 Meeting Demonstrating PP405 Activates Human Hair Follicle Stem Cells Ex Vivo and in Phase 1 Clinical Study
New data shows JNJ-2113, the first and only investigational targeted oral peptide, maintained skin clearance in moderate-to-severe plaque psoriasis through one year
JNJ-2113 long-term extension FRONTIER 2 study demonstrated sustained efficacy from Week 16 to Week 52 and safety results consistent with previously reported data (FRONTIER 1 Study) in a late-breaking oral presentation at the American Academy of Dermatology 2024 Annual Meeting SAN DIEGO, March 9, 2024 /PRNewswire/ — Johnson & Johnson today announced the first… Continue reading New data shows JNJ-2113, the first and only investigational targeted oral peptide, maintained skin clearance in moderate-to-severe plaque psoriasis through one year
First Presentation of Year 4 BIMZELX® (bimekizumab-bkzx) Data Showed Long-Term Maintenance of Complete Skin Clearance in Moderate-to-Severe Plaque Psoriasis
Late-breaking platform presentation showed that BIMZELX® (bimekizumab-bkzx) rapidly achieved and maintained high rates of clinical and health-related quality-of-life responses through four years; six out of ten patients achieved complete skin clearance at Year 4 Responder-analyses demonstrated that approximately nine out of ten patients treated with BIMZELX who achieved PASI90 at Week 16, and over seven… Continue reading First Presentation of Year 4 BIMZELX® (bimekizumab-bkzx) Data Showed Long-Term Maintenance of Complete Skin Clearance in Moderate-to-Severe Plaque Psoriasis
Savory & Partners: Investment Migration Programs Grabbing Investors’ Attention
Investment Migration Experts Predict 2024’s Hotspots for Citizenship and Residency DUBAI, UAE, March 9, 2024 /PRNewswire/ — As global mobility and contingency planning become more crucial for investors, the demand for investment migration programs has surged in popularity. According to reports from leading residency and citizenship by investment firm, Savory & Partners, application volumes have… Continue reading Savory & Partners: Investment Migration Programs Grabbing Investors’ Attention
BizClik Brand Supply Chain Digital Celebrates Monumental Milestone of 100,000 Followers on LinkedIn
Supply Chain Digital continues to build a thriving community of the world’s supply chain leaders, surpassing 100,000 followers on LinkedIn LONDON, March 8, 2024 /PRNewswire/ — Supply Chain Digital, a leading global provider of supply chain and logistics resources, including a top-rated magazine, website, newsletter and events service, proudly announces a significant achievement – surpassing… Continue reading BizClik Brand Supply Chain Digital Celebrates Monumental Milestone of 100,000 Followers on LinkedIn
Cold Chain Logistics Market Size to Grow USD 877710 Million by 2030 at a CAGR of 14.8% | Valuates Reports
Cold Chain Logistics Market is Segmented by Type (Airways, Roadways, Seaways), by Application (Healthcare, Food and Beverages). BANGALORE, India, March 8, 2024 /PRNewswire/ — The Global Cold Chain Logistics Market was valued at USD 330680 Million in 2023 and is anticipated to reach USD 877710 Million by 2030, witnessing a CAGR of 14.8% during the… Continue reading Cold Chain Logistics Market Size to Grow USD 877710 Million by 2030 at a CAGR of 14.8% | Valuates Reports